Skip to main content

Gain inSIGHT into an Immunocompromised Patient’s T Cell Immune Response featuring: CMV & SARS-CoV-2

Join Dr.'s Raval, Khawaja and Kleiboeker to learn more about virus-specific T cell immunity for CMV and SARS-CoV-2. Dr. Raval, a board certified Cardiologist, will share his experience utilizing the CMV T Cell Immunity panel in heart transplant patients. Dr. Khawaja, an Infectious Disease physician, will present his experience with CMV cellular immunity in hematopoietic cell transplant recipients with low level viremia. Finally, Dr. Kleiboeker will describe the new SARS-CoV-2 inSIGHT T Cell Immunity test as well as discuss future T Cell Immunity testing innovations to come. Explore how you can consider integrating T cell immunity testing into your immunocompromised patients.

Length of Presentation: 47 minutes

Presented by: 

  • Dr. Nirav Raval, MD
    Medical Director of Thoracic Transplant
    Transplant Cardiologist Heart
    VAD Program


  • Dr. Fareed Khawaja, MD
    Assistant Professor Department of Infectious diseases
    Infection control and Employee health University of Texas
    MD Anderson Cancer Center

  • Dr.Steve Kleiboeker, PhD
    Vice President of Research and Development
    Eurofins Viracor Clinical Diagnostics
Back to top